This protocol aims to provide long-term follow-up and continued use of research specimens of participants previously enrolled on gene transfer or other immunotherapy studies at the National Cancer Institute as well as follow-up of subjects at extramural sites receiving these agents as part of a multi-site trial. Subjects will undergo an annual health history for up to 15 years.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subjects who received poxviral vectors (vaccinia and/or fowlpox) or other vaccines utilizing gene transfer or any other immunotherapeutic agent through GMB, UOB and LTIB affiliated trials at the National Cancer Institute, as well as subjects at extramural sites receiving these agents as part of a multi-site trial. Available stored specimens obtained from NCI participants in GMB, UOB, and LTIB affiliated protocols may be transferred to this protocol for storage and eventual future research use.
Subjects must be \>= 18 years of age.
You may not be if
Participants unwilling to participate.
(Please note, participants may participate in this protocol and, at the same time, participate in an active treatment or continuing care study.)
Clareo Health | Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
